Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin

Oral anticoagulation therapy is standard of care for patients with nonvalvular atrial fibrillation to prevent stroke. This study compared rivaroxaban and warfarin for stroke and all-cause mortality risk reduction in a real-world setting. METHODS—: This retrospective cohort study (2011–2017) included...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stroke
Autori principali: Alberts, Mark, Chen, Yen-Wen, Lin, Jennifer H., Kogan, Emily, Twyman, Kathryn, Milentijevic, Dejan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2020
Soggetti:
Original Contributions
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004448/
https://ncbi.nlm.nih.gov/pubmed/31888412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.119.025554
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi